Literature DB >> 8558324

Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkeys.

M S Anthony1, T B Clarkson, C L Hughes, T M Morgan, G L Burke.   

Abstract

Although the beneficial effects of dietary soybean protein compared with animal proteins on plasma lipids, lipoproteins and atherosclerosis have been known for about 50 years, it has been uncertain whether these effects are due to its amino acid concentrations or other components in soybeans. To assess the effect of soybean protein's alcohol-extractable components (including the isoflavonic phytoestrogens genistein and daidzein) on plasma lipid and lipoprotein concentrations and to establish its lack of effect on the reproductive system, we fed 27 peripubertal male and female rhesus monkeys moderately atherogenic diets in which the source of dietary protein was a soy isolate (20% by weight), either containing phytoestrogens (also termed isoflavones) or with the phytoestrogens removed by alcohol extraction. The study was a crossover design with each period lasting for 6 mo. The phytoestrogen-intact soy protein (compared with the alcohol-extracted soy protein) had favorable effects on plasma lipid and lipoprotein concentrations, specifically by significantly reducing LDL+VLDL cholesterol concentrations in both males and females (approximately 30-40% lower), significantly increasing high density lipoprotein cholesterol (HDLC) concentrations for females (approximately 15% higher) and significantly lowering total plasma cholesterol (TPC):HDLC ratios (approximately 20% lower for males and 50% lower for females). The phytoestrogens had no adverse effects on the reproductive systems of either the males or females, as evaluated by reproductive hormone concentrations and organ weights at necropsy. Thus, the isoflavones in soy protein improve cardiovascular disease risk factors without apparent deleterious effects on the reproductive system of peripubertal rhesus monkeys.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8558324     DOI: 10.1093/jn/126.1.43

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  52 in total

Review 1.  Therapeutic options: hormone replacement therapy-soy therapy.

Authors:  J C Merritt
Journal:  J Natl Med Assoc       Date:  2001 Jul-Aug       Impact factor: 1.798

Review 2.  Recent advances in understanding the anti-diabetic actions of dietary flavonoids.

Authors:  Pon Velayutham Anandh Babu; Dongmin Liu; Elizabeth R Gilbert
Journal:  J Nutr Biochem       Date:  2013-09-09       Impact factor: 6.048

3.  Complementary medicine for prostate cancer: effects of soy and fat consumption.

Authors:  M A Moyad; W A Sakr; D Hirano; G J Miller
Journal:  Rev Urol       Date:  2001

Review 4.  NTP-CERHR expert panel report on the reproductive and developmental toxicity of soy formula.

Authors:  Karl K Rozman; Jatinder Bhatia; Antonia M Calafat; Christina Chambers; Martine Culty; Ruth A Etzel; Jodi A Flaws; Deborah K Hansen; Patricia B Hoyer; Elizabeth H Jeffery; James S Kesner; Sue Marty; John A Thomas; David Umbach
Journal:  Birth Defects Res B Dev Reprod Toxicol       Date:  2006-08

Review 5.  Therapeutic interventions to enhance apolipoprotein A-I-mediated cardioprotection.

Authors:  Michael J Haas; Arshag D Mooradian
Journal:  Drugs       Date:  2010-05-07       Impact factor: 9.546

Review 6.  Flavonoids and age-related disease: risk, benefits and critical windows.

Authors:  J K Prasain; S H Carlson; J M Wyss
Journal:  Maturitas       Date:  2010-02-23       Impact factor: 4.342

Review 7.  Gonadal hormone substitutes: effects on the cardiovascular system.

Authors:  T B Clarkson; J M Cline; J K Williams; M S Anthony
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

8.  Genistein, a soy phytoestrogen, upregulates the expression of human endothelial nitric oxide synthase and lowers blood pressure in spontaneously hypertensive rats.

Authors:  Hongwei Si; Dongmin Liu
Journal:  J Nutr       Date:  2008-02       Impact factor: 4.798

9.  Increased NO bioavailability in aging male rats by genistein and exercise training: using 4, 5-diaminofluorescein diacetate.

Authors:  Sukanya Eksakulkla; Daroonwan Suksom; Prasong Siriviriyakul; Suthiluk Patumraj
Journal:  Reprod Biol Endocrinol       Date:  2009-09-07       Impact factor: 5.211

10.  Effects of soybean isoflavone extract on the plasma lipid profiles and antioxidant enzyme activity in streptozotocin-induced diabetic rats.

Authors:  Jee-Youn Shim; Yoo Jung Kim; Hye-Sung Lee
Journal:  Nutr Res Pract       Date:  2008-12-31       Impact factor: 1.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.